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Abstract 15 
CoreScan is a new software for the GE Lunar iDXA, which provides a quantification of visceral 16 
adipose tissue (VAT). The objective of this study was to determine the in-vivo precision of CoreScan 17 
for the measurement of VAT mass in a heterogeneous group of adults. 45 adults were recruited for 18 
this study (age 34.6 (8.6) years), ranging widely in body mass index (BMI 26.0 (5.2) kg.m
-2
 (16.7 – 19 
42.4 kg.m
-2
). Each participant received two consecutive total body scans with re-positioning. The 20 
sample was divided into two sub-groups based on BMI, normal and overweight/obese, for precision 21 
analyses. Sub-group analyses revealed precision (RMS-SD:%CV) for VAT mass were 20.9g:17.0% in 22 
normal and 43.7g:5.4% in overweight/obese groups. Our findings indicate that the precision error for 23 
VAT mass increases with increasing BMI but caution should be used with %CV derived precision 24 
error in normal BMI subjects. 25 
 26 
  27 
KEY WORDS: DXA; reproducibility; visceral fat; body composition28 
3 
 
Introduction 29 
Clinical investigations have demonstrated close relationships between regional fat mass and disease 30 
risk, mainly the association of trunk fat with the clustering of cardio-metabolic risk factors associated 31 
with metabolic syndrome (1).  Abdominal obesity is also an independent predictor of all-cause 32 
mortality (2). Computed tomography (CT) is the gold standard assessment of visceral adipose tissue 33 
(VAT) but it is expensive and the high radiation exposure suggests the risks would outweigh the 34 
benefits if used as a screening tool. Dual-energy X-ray absorptiometry (DXA) provides a precise 35 
measurement of three compartment body composition (3). GE have recently introduced CoreScan; a 36 
new tool for the quantification of VAT, which has been validated with CT in healthy men and women 37 
(4). The advantages of using DXA over CT include the lower radiation exposure and greater time 38 
efficiency.  39 
 40 
It is important to determine in-vivo precision of all DXA measurements for interpretation of results 41 
and patient monitoring. The purpose of this study was to ascertain the short term in-vivo precision of 42 
the GE Lunar iDXA CoreScan software for the measurement of VAT mass in normal, overweight and 43 
obese adults.   44 
 45 
Materials/Subjects and Methods 46 
Forty five men (n=10) and women (n=35) received two consecutive total body DXA scans with re-47 
positioning, after providing signed informed consent to participate in the study approved by the 48 
Institution’s Research Ethics Committee and in accordance with the Declaration of Helsinki.  49 
 50 
Participants were measured wearing light weight clothing and all jewellery was removed. Height was 51 
determined with a stadiometer (SECA, Birmingham, UK) to the nearest 0.1cm, and body weight was 52 
recorded by calibrated electronic scales (SECA, Birmingham, UK) to the nearest 0.1kg. BMI was 53 
calculated as body mass in kilograms/ height in metres squared. Scans were conducted on a fan-beam 54 
GE Lunar iDXA using standard (153mm/sec) or thick (80mm/sec) mode depending on body stature. 55 
Participants were placed in the supine position on the scanning table with the body aligned with the 56 
4 
 
central horizontal axis. Arms were positioned parallel to, but not touching the body. Forearms were 57 
pronated with hands flat on the bed. Legs were fully extended and feet were secured with a canvas 58 
and Velcro support to avoid foot movement during the scan acquisition. Each participant was re-59 
positioned between scans, after dismounting the scanning table. One skilled technologist led and 60 
analysed all scans following the manufacturer’s guidelines for patient positioning. Identical scanning 61 
parameters were used for each scan. The regions of interest for the total body cut-offs were manually 62 
adjusted according to the manufacturer’s instructions. The ROI over the android region for the 63 
assessment of VAT was automated by the software. Scan analyses were performed using the Lunar 64 
Encore software (Version 15). The machine’s calibration was checked and passed on a daily basis 65 
using the GE Lunar calibration hydroxyapatite and epoxy resin phantom. There was no significant 66 
drift in calibration for the study period.  67 
 68 
Statistics 69 
Data analysis was computed using Microsoft Excel 2010 and IBM SPSS Statistics software (Version 70 
21). Participant descriptive data are reported as the mean and standard deviation (SD). The precision 71 
error is represented as the square root of the mean of the sum of the squares of differences between 72 
measurement 1 and measurement 2. The precision parameters, the root-mean-square standard 73 
deviation (RMS-SD), %CV (RMS-%CV), intra-class correlation coefficient (ICC) and the resulting 74 
least significant changes (LSC) were calculated manually. The %CV is derived from the equation: 75 
%CV = (SD/mean value) * 100. 76 
Bland Altman analysis was used to compare the paired measurements (5). 77 
 78 
Results and Discussion 79 
According to the World Health Organisation BMI guidelines, 4% participants were underweight 80 
(n=2), 47% were classified as normal weight (n=21), 29% were overweight (n=13) and 20% obese 81 
(n=9). For analysis, the underweight and normal weight category were combined to form the ‘normal 82 
weight group’ (BMI = 22.1 (2.2) kg.m-2; Age = 33.2 (8.6); n=20 female; n=3 male) with a range of 83 
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16.7-24.9 kg.m
-2
; and the overweight and obese weight categories were combined to form a group 84 
(BMI = 30.0 (4.4) kg.m
-2
; Age = 35.9 (9.0); n=15 female; n=7 male) with a rang of 25.5-42.4 kg.m
-2
.  85 
 86 
The overweight/obese group had greater VAT mass (mean of two measurements - normal  87 
: 123 (104)g; overweight/obese: 806.5 (564)g. Figure 1a and 1b illustrate Bland Altman VAT mass 88 
analysis for the two  groups.  For the normal BMI groups, mean of the differences = -2.3 ± 30.2 with 89 
limits of agreement -62.3g to 57.7g.  For the overweight/obese group mean of the differences = 15.9 ± 90 
61.1g with limits of agreement  -106g to 138g was observed.  Although the mean of the differences 91 
were small the range of inter-measurement differences increased with BMI. No magnitude effects 92 
were observed from Bland Altman analysis. 93 
 94 
Table 1 shows the VAT mass precision and LSC at 95%CI for both groups and precision values 95 
determined from previous studies.  For RMS-SD precision values, the normal BMI groups have a 96 
lower precision error: 20.9g but increased precision error with %CV: 17.0, compared to the 97 
overweight/obese group, 43.7g and 5.4% respectively. This is due to %CV being dependant on its 98 
inverse relationship with the mean value and in this study mean values of the two groups are different: 99 
123g - 806g, resulting in the observed differences in %CV. Therefore the 95%CI derived from RMS-100 
SD is the more reliable estimate. Our precision estimates for the overweight/obese group are in close 101 
agreement with the obese group precision values determined by Rothery et al (6). In the study of 102 
severely obese subjects by Carver et al (7) there is an marked increased in the RMS-SD precision 103 
error but only a small increase in the %CV precision error compared to the obese subjects due to the 104 
higher VAT mass mean value in the severely obese group.  105 
 106 
We investigated precision error of the GE CoreScan VAT software in a heterogeneous sample of 107 
adults. This sample was representative of the usual research participants who attend our DXA centre. 108 
Using RMS-SD there was a small increase in the imprecision error with BMI in our study groups 109 
(20.9g compared to 43.7g). The RMS-SD and %CV precision values for the overweight/obese are 110 
similar to those reported by Rothney et al (6) due to the similar mean VAT masses. Our findings 111 
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differ to those of Carver et al (7) who reported a RMS-SD precision for a severely obese group of 112 
294g. A limitation of the study is that the effect of gender could not be investigated due to the low 113 
numbers of males. It should therefore provide a valuable avenue for future research.  114 
 115 
We, and others, have previously reported excellent in vivo precision for iDXA measurements of total 116 
fat mass and total lean mass, regardless of BMI (3, 8). As suggested elsewhere, the visceral region is 117 
relatively small and the mathematical complexities to distinguish VAT from subcutaneous fat may 118 
lead to greater precision error (6). In conclusion, iDXA CoreScan provides good precision for VAT 119 
measurements for individuals with a BMI between 25.5 – 42.4 kg.m-2, This study and comparisons 120 
with previous studies also highlights that the %CV value for precision should not be used when study 121 
population mean vales differ as observed in this study. 122 
 123 
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Table Legends 147 
Table 1: Precision comparison between two separate measurements of VAT mass. 148 
 149 
Figure Legends 150 
 151 
Figure 1: Bland-Altman plot between two measurements of VAT mass in the a) normal BMI group 152 
and b)  the overweight and obese group 153 
 154 
155 
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Table 1 156 
BMI Classification n BMI 
(kg/m
2
) 
 Vat  Mass (g) RMS-SD(g) %CV 
     LSC(95%CI)  LSC(95%CI) 
Normal* 23 (20f/3m) 22.1(2.2) 123 20.9 59.1 17.0 48.1 
Overweight/Obese* 22 (15f /7m) 30.0(4.4) 806 43.7 123.6 5.4 15.3 
Obese (6) 32f 35.1(3.1) 1110 56.8 160.7 5.1 14.4 
Severely Obese (7) 55(36f/19m) 49.0(6.0) 3250 294.0 832.0 8.7 24.9 
 157 
*Mellis et al (2014) - current study results 
KEY: RMS-SD - Root Mean Square of the Successive Differences; CV - Coefficient of Variation; LSC 95% CI - Least 
Significant Change at 95% Confidence Intervals  
 158 
159 
9 
 
0 100 200 300 400 500
-200
-150
-100
-50
0
50
100
150
200
D
if
fe
re
n
c
e
 i
n
 p
a
ir
e
d
 V
A
T
 M
a
s
s
 (
g
)
Mean paired VAT Mass (g)
mean = -2.3g 
LOA = 57.7g
LOA = - 62.3g
Fig 1 a
 160 
 161 
0 500 1000 1500 2000
-200
-150
-100
-50
0
50
100
150
200
D
if
fe
re
n
c
e
s
 i
n
 p
a
ir
e
d
  
V
A
T
 M
a
s
s
 (
g
)
Mean paired VAT Mass(g)
mean = 15.9g
LOA = 138g
LOA = -106g
Fig 1b
 162 
